EXCLUSIVE: Scienture Commences Commercial Launch and Fulfillment of Initial Rezenopy Orders; Targets Execution Through End of 2026 By Expanding Payer Coverage, Product Access, and Institutional Adoption

Benzinga Newsdesk www.benzinga.com Positive 85.8%

Neg 0% Neu 0% Pos 85.8%

Comments

No comments yet. Be the first!